Prevalence of hematopoietic cell transplant survivors in the United States. - Wikidata - wikimedia - TriplyDB

Prevalence of hematopoietic cell transplant survivors in the United States.

Prevalence of hematopoietic cell transplant survivors in the United States.

http://www.wikidata.org/entity/Q37188807

about

Next-generation long-term transplant clinics: improving resource utilization and the quality of care through health information technology Secondary solid cancer screening following hematopoietic cell transplantation National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: Consensus Recommendations for Subsequent Neoplasms Late Effects Screening Guidelines after Hematopoietic Cell Transplantation (HCT) for Inherited Bone Marrow Failure Syndromes (IBMFS): Consensus Statement From the Second Pediatric Blood and Marrow Transplant Consortium International Conference on La The Second Pediatric Blood and Marrow Transplant Consortium International Consensus Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: Defining the Unique Late Effects of Children Undergoing Hematopoietic Cell Transplanta Trajectories of Quality of Life after Hematopoietic Cell Transplantation: Secondary Analysis of Blood and Marrow Transplant Clinical Trials Network 0902 Data.National Survey of Hematopoietic Cell Transplantation Center Personnel, Infrastructure, and Models of Care Delivery Hormone Use for Therapeutic Amenorrhea and Contraception During Hematopoietic Cell Transplantation Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation.Hematopoietic Stem Cell Transplant in Elderly Patients: Experience from a Tertiary Care Centre in Northern India.Metabolic Syndrome and Cardiovascular Disease after Hematopoietic Cell Transplantation: Screening and Preventive Practice Recommendations from the CIBMTR and EBMT Sexual health in hematopoietic stem cell transplant recipients.National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: Developing Recommendations to Improve Survivorship and Long-Term Outcomes.National Institutes of Health Blood and Marrow Transplant Late Effects Initiative: The Healthcare Delivery Working Group Report.Process of allogeneic hematopoietic cell transplantation decision making for older adults.Childhood to adult transition and long-term follow-up after blood and marrow transplantation.Long-term complications after hematopoietic cell transplantation.Survival and Late Effects after Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancy at Less than Three Years of Age.Long-Term Survivorship after Hematopoietic Cell Transplantation: Roadmap for Research and Care.Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT.Geographic access to hematopoietic cell transplantation services in the United States.Morbidity and Mortality Differences Between Hematopoietic Cell Transplantation Survivors and Other Cancer Survivors.Association of socioeconomic status with long-term outcomes in 1-year survivors of allogeneic hematopoietic cell transplantation.Neurocognitive Dysfunction in Hematopoietic Cell Transplant Recipients: Expert Review From the Late Effects and Quality of Life Working Committee of the CIBMTR and Complications and Quality of Life Working Party of the EBMT.Cardiovascular Function in Long-Term Hematopoietic Cell Transplantation Survivors.PROMIS measures can be used to assess symptoms and function in long-term hematopoietic cell transplantation survivors.Quality of life among boys with adrenoleukodystrophy following hematopoietic stem cell transplant.Lifestyle factors and subsequent ischemic heart disease risk after hematopoietic cell transplantation.Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT.Musculoskeletal complications following total body irradiation in hematopoietic stem cell transplant patients.Long term survival among patients who are disease free at 1-year post allogeneic hematopoietic cell transplantation: a single center analysis of 389 consecutive patients.Pilot study of a multimodal intervention to enhance sexual function in survivors of hematopoietic stem cell transplantation.Real-world economic burden of hematopoietic cell transplantation among a large US commercially insured population with hematologic malignancies.

P2860

Q26787225-4E0F9163-E2F3-45F0-B333-C67E8F8DE0FE Q28088369-F02D8362-7FB9-473B-8DA3-7D2BC7EDFD93 Q29248394-8D28B358-5CC6-41AA-80D7-931FCF1F65A6 Q30234389-1D9A2DBB-9656-4D79-B7BE-CCA22CE3A38A Q30244617-61FC75D9-89A9-4F2E-9785-90553725BEF3 Q31122330-91B4283C-DB16-4930-AA61-0D78F594A6A2 Q35738603-0A49AB4C-C7C6-4C1F-9ACF-45A2B34DCCA7 Q36087035-7E9A54AD-31B4-4FB9-B47B-9D2985F8F19F Q36794295-11BBE4DB-F8E1-4F26-9749-F1F5D05FC590 Q37048479-C5473882-A6C2-4B4D-B2A7-B08A3496FCFC Q37104278-110E81AE-CDE6-4AA6-BCD0-B221F4DD0276 Q37239517-BFF6E1E8-0DFD-4CAA-9A86-1F9F0F3982C8 Q38374821-76AE0EF3-4142-4362-B111-CE3EB1255CD9 Q38376913-B9C1CB9A-A9D7-4F7B-BB6B-333080F5E738 Q38604903-FDF4D5B6-F84D-4E53-93FC-19EE73D5BBFA Q38661120-2CF6AE67-E1CF-4C6A-8721-567924C8B145 Q38667959-9B8003A7-E5D1-481D-8603-527374533ACB Q38688824-A2C173CE-8AB9-48FF-A360-66C46DAF6CCA Q38798042-63D8F145-1F4D-415A-86AD-90FB554BF75C Q38933848-35ABC43F-4B5D-4FB1-A7C9-53952EB0ECA1 Q38954415-1A1BE956-8740-466F-965A-B77821A8DC15 Q40442400-B1D2B324-58EB-48E5-9A35-8DA655ADE75F Q40718203-ACE3F372-1628-4EA1-8031-8060E3912B5D Q41995096-088373A2-3DD1-42AE-9F3E-467A6B38B819 Q46015912-C072A770-32A9-403E-8CA0-BD44E2AF29F0 Q47588548-82CFAAF6-0ADB-4C09-B72D-9A81F85C28D5 Q47616890-68ACB44A-303E-4BAA-BD11-EAB177551C35 Q47743601-4E613049-36B4-4148-BE52-4BDE3B3AF470 Q48222982-60641044-AD76-4362-BE3B-151A9A259608 Q48332039-119E5B4A-96A1-473C-ADF0-BF34B551D601 Q50042357-6A87A675-6649-461B-A9F5-D2142DCFBF87 Q52656296-306A9D2E-CE11-4AA7-8483-FB368A6DD3E3 Q53123065-291E61D7-0C7D-4FB7-BE79-85E061C9B688

P2860

Prevalence of hematopoietic cell transplant survivors in the United States.

http://www.wikidata.org/entity/Q37188807

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 30 July 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Prevalence of hematopoietic cell transplant survivors in the United States.

@en

Prevalence of hematopoietic cell transplant survivors in the United States.

@nl

type

label

Prevalence of hematopoietic cell transplant survivors in the United States.

@en

Prevalence of hematopoietic cell transplant survivors in the United States.

@nl

prefLabel

Prevalence of hematopoietic cell transplant survivors in the United States.

@en

Prevalence of hematopoietic cell transplant survivors in the United States.

@nl

P1433

Q37188807-EBF27F57-BE9E-41DD-BA53-2144AF469D5F

P1476

Q37188807-C0CD1893-56D5-4954-B1D1-A9D7943DB6FB

P2093

Q37188807-03841A43-0E88-4BA9-8171-081CF5869019

Q37188807-0A2A2E0A-532B-4271-959E-02B76CD678CB

Q37188807-344656E3-8F8E-403A-9B00-F20361950069

Q37188807-3EC3A309-ABAD-4858-B471-C37478B5F4D2

Q37188807-42189CA5-F589-4C2C-B6D2-E88D7A567A72

Q37188807-6360926E-6B19-4312-822E-12DE8C607116

Q37188807-8098483A-492F-4939-A72E-DD552DA5A9C9

Q37188807-B5CD207B-A6BF-41C6-893F-19F292F1E2FE

Q37188807-EF4DA34C-873A-4AF3-827F-690100A61AD1

Q37188807-F5DA8544-B8A4-4A61-A1A9-37BF04344567

P2860

Q37188807-03733FBB-ECBB-41CD-8CA7-1DCE9BFE0D02

Q37188807-08CF1AEE-1630-4F71-993A-666BF3230D1D

Q37188807-09C1A933-6033-4278-AA6F-297CE0BB644E

Q37188807-2181DC28-E210-4AA4-A970-36EC6389B261

Q37188807-31F759E4-F9AA-49C7-908B-63C46EF32E2D

Q37188807-34A2C76B-8967-4BA5-8BBB-C61626DCFCD0

Q37188807-42F2C381-C9E1-4A11-971F-7302FBCED3C0

Q37188807-46CF82CC-E9B0-42AC-82B9-95227F0C5395

Q37188807-492D795B-27AF-46AB-8EAE-98BAC2C28819

Q37188807-50EF7691-68C1-45B6-A290-A5583FBC6F7F

P304

Q37188807-62094F82-4F93-4835-A20C-7D7E4723B59C

P31

Q37188807-CEC072F9-112A-4DED-AFB0-22254064BAE5

P356

Q37188807-118C5C8D-D837-4745-A9AC-35C287F1AD1B

P433

Q37188807-7A00DB34-0A3B-4920-962E-E944F5A92AB9

P478

Q37188807-F1F08D4A-9CB1-4316-B70B-2DB4595242D5

P50

Q37188807-12DFD61E-FA1E-4A8A-826F-B2C170DB9623

Q37188807-5092FE98-162F-4703-BFD2-E4BA0A941706

Q37188807-93B62C2D-C965-433B-A854-402E06CFE50D

Q37188807-ACBBA72D-88BC-4DE1-9BDB-9006DDEC21C9

P577

Q37188807-86A2E5C2-C965-49A9-9B07-4D64C55E6BC0

P5875

Q37188807-112DCAFF-63D0-4A98-9BAB-CDC320576089

P698

Q37188807-90B16BA7-01B3-4D28-8CE3-F7F01BC18624

P921

Q37188807-E3B6AD17-040B-40EA-969D-402076CA1FE6

P932

Q37188807-82E5E6E1-ABAF-45F0-87AB-DBF21F2B5D7F

P356

J.BBMT.2013.07.020

P1433

Biology of Blood and Marrow Transplantation

P1476

Prevalence of hematopoietic cell transplant survivors in the United States.

@en

P2093

Ann Jakubowski

http://www.w3.org/2001/XMLSchema#string

Christopher Bredeson

http://www.w3.org/2001/XMLSchema#string

James L Gajewski

http://www.w3.org/2001/XMLSchema#string

Jason Dehn

http://www.w3.org/2001/XMLSchema#string

Karen M Kuntz

http://www.w3.org/2001/XMLSchema#string

Li Tao

http://www.w3.org/2001/XMLSchema#string

Navneet S Majhail

http://www.w3.org/2001/XMLSchema#string

Stella Davies

http://www.w3.org/2001/XMLSchema#string

Susan K Parsons

http://www.w3.org/2001/XMLSchema#string

Theresa Hahn

http://www.w3.org/2001/XMLSchema#string

P2860

Delivering care to long-term adult survivors of hematopoietic cell transplantation.

Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation.

Relapse and late mortality in 5-year survivors of myeloablative allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in first chronic phase.

High probability of long-term survival in 2-year survivors of autologous hematopoietic cell transplantation for AML in first or second CR.

Reduced mortality after allogeneic hematopoietic-cell transplantation.

How I treat late effects in adults after allogeneic stem cell transplantation.

Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made?

Long-term survival and late deaths after allogeneic hematopoietic cell transplantation.

Allogeneic transplant physician and center capacity in the United States.

Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.

P304

1498-1501

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BBMT.2013.07.020

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

Stephanie J Lee

Hillard M Lazarus

P577

2013-07-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

254263868

http://www.w3.org/2001/XMLSchema#string

P698

23906634

http://www.w3.org/2001/XMLSchema#string

P921

Ameeriga Ütisriigiq

P932

3779514

http://www.w3.org/2001/XMLSchema#string